[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [BUSINESS]

4 clusters · 12 sources · 35 days · First seen · Last updated

Munich Re financial performance and stock trend

Overview

In mid‑July 2026 Munich Re’s shares regained momentum, breaking above the 100‑day moving average and retaking the €507.20 support level, with the next hurdle near the 200‑day average at €524.16. The insurer’s 2024 results, released shortly after, confirmed disciplined underwriting, higher gross premiums and a solid loss‑cost ratio, prompting a dividend increase to a high‑single‑digit or low‑double‑digit euro amount per share and underscoring a strong solvency position. Provisional Q2 2026 figures announced at the end of July showed a net profit of €2.2 billion, well ahead of forecasts, driven by a low large‑loss burden in casualty‑and‑accident lines and a €300 million contribution from ERGO. The group had already booked €3.9 billion in profit for the first half‑year, about 62% of its €6.3 billion annual target, and the CEO described the trajectory as “very good.”

The CFO warned of possible premium‑price pressure in July, and the share price slipped modestly after the earnings beat. On 7 August, Munich Re revised its 2026 revenue outlook, lowering the insurance revenue target to €62 billion (from €64 billion) and the reinsurance revenue target to €38 billion (from €40 billion) after a 9.1% drop in July renewal volume and a 5.5% price decline. Despite this, the company reported a strong half-year net result of nearly €4 billion, keeping it on track to meet its €6.3 billion annual profit target. Following these reports, Munich Re shares declined by 1.64% to close at €514.60. By 16 August, reports reaffirmed that Munich Re achieved a record profit of €3.9 billion for the first six months of the year, despite the slight downward adjustment to its full-year insurance revenue outlook.

Entities

EvoNext Holdings SA · Bernard de Roos · Swiss Re · Marsh & McLennan · Vontobel

Timeline

  1. 26 days ago

    [BUSINESS] 7 sources
    EvoNext Holdings confirms advanced merger talks with Ascend Sport Technology

    EvoNext Holdings is in advanced merger talks with Ascend Sport Technology. Meanwhile, Swiss Re and Munich Re report strong half-year profits, and Marsh & McLennan sees steady revenue growth.

  2. about 2 months ago

    [BUSINESS] 2 sources
    Munich Re posts strong Q2 profit, beats forecasts despite pricing pressure

    Munich Re posted a €2.2 bn Q2 profit, beating forecasts by ~23 %, aided by low loss claims and strong investments, but warned of possible premium price pressure and saw its shares dip.

  3. about 2 months ago

    [BUSINESS] 2 sources
    Munich Re posts solid 2024 earnings and raises dividend

    Munich Re's 2024 earnings rose on disciplined underwriting, higher premiums and a solid loss ratio, while a stronger capital position enabled an increased dividend.

  4. 2 months ago

    [BUSINESS] 2 sources
    Munich Re Shares Rise Toward 100‑Day Moving Average

    Munich Re stock climbed intraday, retaking the €507.20 support and eyeing the 100‑day average, with the next hurdle at €524.16.

Sources

ad-hoc-news.de · biotech-investments.com · cash.ch · cryptobriefing.com · finanzen.ch · finanznachrichten.de · it-boltwise.de · jkadworld.com · kapitalmarktexperten.de · sharedeals.de · versicherungsjournal.at · wochentlich.de

This summary has been updated 4 times: see revision history